LT3083676T - Naujos eukariotinės ląstelės, ir dominančio polipeptido rekombinantinės raiškos būdai - Google Patents

Naujos eukariotinės ląstelės, ir dominančio polipeptido rekombinantinės raiškos būdai

Info

Publication number
LT3083676T
LT3083676T LT14821859T LT14821859T LT3083676T LT 3083676 T LT3083676 T LT 3083676T LT 14821859 T LT14821859 T LT 14821859T LT 14821859 T LT14821859 T LT 14821859T LT 3083676 T LT3083676 T LT 3083676T
Authority
LT
Lithuania
Prior art keywords
interest
methods
product
eukaryotic cells
recombinantly expressing
Prior art date
Application number
LT14821859T
Other languages
English (en)
Inventor
Thomas Jostock
Holger Laux
Anett Ritter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52278687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3083676(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of LT3083676T publication Critical patent/LT3083676T/lt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00Cells for large scale production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
LT14821859T 2013-12-20 2014-12-18 Naujos eukariotinės ląstelės, ir dominančio polipeptido rekombinantinės raiškos būdai LT3083676T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919313P 2013-12-20 2013-12-20
PCT/IB2014/067073 WO2015092735A1 (en) 2013-12-20 2014-12-18 Novel eukaryotic cells and methods for recombinantly expressing a product of interest

Publications (1)

Publication Number Publication Date
LT3083676T true LT3083676T (lt) 2019-11-25

Family

ID=52278687

Family Applications (1)

Application Number Title Priority Date Filing Date
LT14821859T LT3083676T (lt) 2013-12-20 2014-12-18 Naujos eukariotinės ląstelės, ir dominančio polipeptido rekombinantinės raiškos būdai

Country Status (18)

Country Link
US (2) US11203631B2 (lt)
EP (2) EP3083676B1 (lt)
JP (1) JP6708548B2 (lt)
KR (1) KR102288857B1 (lt)
CN (1) CN106029692A (lt)
AU (1) AU2014369175B2 (lt)
BR (1) BR112016013443B1 (lt)
CA (1) CA2934411C (lt)
DK (1) DK3083676T3 (lt)
ES (1) ES2758504T3 (lt)
IL (1) IL245854B (lt)
LT (1) LT3083676T (lt)
MX (1) MX371025B (lt)
PL (1) PL3083676T3 (lt)
PT (1) PT3083676T (lt)
RU (1) RU2720525C2 (lt)
SG (1) SG11201604215XA (lt)
WO (1) WO2015092735A1 (lt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015502165A (ja) * 2011-12-22 2015-01-22 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 発現ベクター構成、新規の産生細胞生成法、およびポリペプチドの組換え産生のためのそれらの使用
CN106029692A (zh) 2013-12-20 2016-10-12 诺华股份有限公司 用于重组表达感兴趣产物的新型真核细胞和方法
RU2712507C2 (ru) 2013-12-20 2020-01-29 Новартис Аг Новые эукариотические клетки и способы их получения для рекомбинантной экспрессии представляющего интерес продукта
EP3015475A1 (en) 2014-10-31 2016-05-04 Novartis AG Mammalian cells expressing cytomegalovirus antigens
EP3048114A1 (en) 2015-01-22 2016-07-27 Novartis AG Cytomegalovirus antigens and uses thereof
US20190024114A1 (en) * 2016-01-14 2019-01-24 Anton Bauer Method of producing a production cell line
UY37758A (es) 2017-06-12 2019-01-31 Novartis Ag Método de fabricación de anticuerpos biespecíficos, anticuerpos biespecíficos y uso terapéutico de dichos anticuerpos
CN107723276B (zh) * 2017-11-02 2021-08-13 上海交通大学 一种稳定高表达目标产物的细胞株的构建方法和试剂盒
CN107828738A (zh) * 2017-11-28 2018-03-23 新乡医学院 一种dna甲基转移酶缺陷型cho细胞系及其制备方法及应用
UY38299A (es) 2018-07-18 2020-02-28 Novartis Ag Apirasas solubilizadas, métodos y usos
CA3134705A1 (en) * 2019-04-02 2020-10-08 Chugai Seiyaku Kabushiki Kaisha Method of introducing target-specific foreign gene
CN112852874B (zh) * 2021-02-04 2023-05-23 中国农业科学院兰州兽医研究所 Hdac5基因敲除的bhk-21细胞系及其构建方法和应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2585532B2 (ja) 1986-05-10 1997-02-26 三井東圧化学株式会社 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてt−PAを生産する方法
DE69128037T2 (de) 1990-11-13 1998-05-07 Immunex Corp., Seattle, Wash. Bifunktionelle wählbare fusionsgene
AU660671B2 (en) 1991-03-29 1995-07-06 Genentech Inc. Methods for selection of recombinant host cells expressing high levels of a desired protein
CA2163427A1 (en) 1993-05-21 1994-12-08 Stephen D. Lupton Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
JP4031154B2 (ja) * 1999-07-30 2008-01-09 独立行政法人科学技術振興機構 遺伝子増幅細胞の迅速選択法
JP2004538002A (ja) 2001-08-02 2004-12-24 アルタナ ファルマ アクチエンゲゼルシャフト 停止コドン抑制による組み換え遺伝子発現の新規方法
US20050221325A1 (en) 2002-05-22 2005-10-06 Greg Thill Detection of secreted polypeptides
WO2004035732A2 (en) 2002-08-29 2004-04-29 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use
JP5171033B2 (ja) 2003-03-11 2013-03-27 メルク セローノ ソシエテ アノニム mCMVIE2プロモーターを含んで成る発現ベクター
WO2005073375A1 (en) 2004-01-30 2005-08-11 Maxygen Holdings Ltd. Regulated stop codon readthrough
US20050272061A1 (en) 2004-02-19 2005-12-08 Seattle Genetics, Inc. Expression profiling in non-small cell lung cancer
IL165484A0 (en) 2004-11-30 2006-01-15 Applied Research Systems Production of proteins
ES2573027T3 (es) 2006-05-17 2016-06-03 F. Hoffmann-La Roche Ag Células productoras de polipéptido
EP2078075B1 (en) 2006-10-30 2015-09-02 Eli Lilly and Company Random homozygous gene perturbation to enhance antibody production
US20080116234A1 (en) 2006-11-17 2008-05-22 3M Innovative Properties Company Ribbon curling device
EA018840B1 (ru) * 2007-02-15 2013-11-29 ДСМ АйПи АССЕТС Б.В. Рекомбинантная клетка-хозяин для получения соединения, представляющего интерес
MX2010001319A (es) * 2007-08-07 2010-06-01 Chugai Pharmaceutical Co Ltd Metodo para producir proteinas heterogeneas.
CN101903526B (zh) 2007-12-21 2014-02-12 诺华股份有限公司 有机化合物
RU2389628C1 (ru) * 2008-08-18 2010-05-20 Закрытое акционерное общество Научная организация "Тверской институт вагоностроения" (ЗАО НО "ТИВ") Привод тормоза вагона
PL2329020T3 (pl) 2008-08-28 2013-08-30 Novartis Ag Prezentacja izoform polipeptydu na powierzchni komórki poprzez nadczytywanie kodonu stop
SG173456A1 (en) 2009-02-27 2011-09-29 Novartis Ag Expression vector system comprising two selection markers
JP2012526535A (ja) 2009-05-15 2012-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング NoCRの発現が低下した改良細胞系及びその使用
RU2712507C2 (ru) 2013-12-20 2020-01-29 Новартис Аг Новые эукариотические клетки и способы их получения для рекомбинантной экспрессии представляющего интерес продукта
CN106029692A (zh) 2013-12-20 2016-10-12 诺华股份有限公司 用于重组表达感兴趣产物的新型真核细胞和方法

Also Published As

Publication number Publication date
US20220298228A1 (en) 2022-09-22
JP2017500868A (ja) 2017-01-12
CA2934411A1 (en) 2015-06-25
AU2014369175B2 (en) 2017-03-02
EP3604331A1 (en) 2020-02-05
RU2016129285A (ru) 2018-01-25
ES2758504T3 (es) 2020-05-05
JP6708548B2 (ja) 2020-06-10
EP3083676A1 (en) 2016-10-26
AU2014369175A1 (en) 2016-06-16
CA2934411C (en) 2022-05-03
SG11201604215XA (en) 2016-07-28
BR112016013443A2 (pt) 2017-09-26
KR20160101981A (ko) 2016-08-26
DK3083676T3 (da) 2019-11-25
RU2720525C2 (ru) 2020-04-30
EP3083676B1 (en) 2019-08-28
PT3083676T (pt) 2019-11-20
BR112016013443B1 (pt) 2022-11-29
CN106029692A (zh) 2016-10-12
MX371025B (es) 2020-01-13
PL3083676T3 (pl) 2020-02-28
WO2015092735A1 (en) 2015-06-25
US20170002059A1 (en) 2017-01-05
MX2016008249A (es) 2016-09-29
KR102288857B1 (ko) 2021-08-11
IL245854A0 (en) 2016-07-31
US11203631B2 (en) 2021-12-21
IL245854B (en) 2021-06-30

Similar Documents

Publication Publication Date Title
IL245854A0 (en) New eukaryotic cells and methods for recombinant expression of the desired product
IL245856A0 (en) New eukaryotic cells and methods for recombinant expression of the desired product
SG10201705926YA (en) Methods for improved production of rebaudioside d and rebaudioside m
EP2884550A4 (en) THERMOELECTRIC IMPLEMENTATION MATERIAL AND MANUFACTURING METHOD THEREFOR
HK1223127A1 (zh) 生物柴油的生產及由此獲得的產品
EP3096633C0 (en) INSECT PRODUCTS, METHODS OF THEIR PRODUCTION AND USE
GB201315507D0 (en) Container and method of manufacture
IL248184B (en) Novel invertebrate cells and methods for recombinant expression of a desired polypeptide
GB201301639D0 (en) Product and process
PL2964545T3 (pl) Ulepszone opakowanie i sposób wytwarzania takiego opakowania
GB201308195D0 (en) Aluminium Alloy Products and Methods of Making Such Alloy Products
GB201315736D0 (en) Insulating methos and product
ZA201507409B (en) Retro-aldol reaction products and methods of making and using same
GB201322321D0 (en) A product and method of making a product
ZA201305839B (en) Containers and methods of erectiing containers
GB201310961D0 (en) Process for producting biodiesel and related products
GB201304585D0 (en) Methods and product
GB201318453D0 (en) Novel method and products
GB201317888D0 (en) Method and product
AU2013901905A0 (en) Improved Container Construction and Method of Handling
GB201307902D0 (en) Potash Product and Method
GB201321103D0 (en) Novel process and products
GB201300358D0 (en) Method and product
GB201308979D0 (en) Analysis, design and production of products comprising superelastic materials
GB201213453D0 (en) Material and method of production